GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Current Accrued Expense

Divi's Laboratories (NSE:DIVISLAB) Current Accrued Expense : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Current Accrued Expense?

Divi's Laboratories's Current Accrued Expense for the quarter that ended in Dec. 2023 was ₹0 Mil.

Divi's Laboratories Current Accrued Expense Historical Data

The historical data trend for Divi's Laboratories's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Current Accrued Expense Chart

Divi's Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Divi's Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Divi's Laboratories Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Divi's Laboratories Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories (NSE:DIVISLAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Current Accrued Expense
Comparable Companies
BOM:500124 BOM:543904 NSE:TORNTPHARM BOM:532321 BOM:500257 NSE:AUROPHARMA NSE:ALKEM BOM:524494 BOM:532331 BOM:506943 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
532488:India
Address
Divi Towers, 1-72/23(P)/DIVIS/303, Babukhan Lane, Cyber Hills, Gachibowli, Hyderabad, TG, IND, 500032
Website
https://www.divislabs.com
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Divi's Laboratories (NSE:DIVISLAB) Headlines

No Headlines